Catalyst Funds Management Pty LTD Bio Rad Laboratories, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 4,700 shares of BIO stock, worth $1.14 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
4,700
Previous 4,700
-0.0%
Holding current value
$1.14 Million
Previous $1.57 Billion
1.81%
% of portfolio
0.38%
Previous 0.35%
Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
476Shares Held
18.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$468 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$378 Million0.01% of portfolio
-
Veritas Asset Management LLP977KShares$238 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$182 Million0.06% of portfolio
-
Van Eck Associates Corp723KShares$176 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...